KING CITY, CA, USA and VANCOUVER, BC, CANADA (October 21, 2021) – Segra International Corp., an agriculture technology company and The Vertis Group, a leading California cannabis producer, are pleased to announce a strategic partnership that will bring Segra’s proprietary plant tissue culture technologies to bolster Vertis’s state-of-the-art cannabis production operation in King City, California.
Under the agreement terms, Segra is developing a plant tissue culture laboratory on-site at the Vertis facility to prepare numerous high-value cultivars for the ongoing production of clean stock cannabis plantlets. Segra’s best-in-class tissue culture, DNA fingerprinting, and pathogen diagnostics technologies will ensure Vertis’s ability to produce standardized, clean stock young plants to power its rapidly expanding operations. Construction of the lab is currently underway, with operations planned to commence in early December.
Vertis operates one of the largest indoor cannabis production and processing facilities in California. With over 400,000 square feet of production and processing under development at its flagship facility, Vertis is positioned to take a strong leadership position in producing high-grade indoor cannabis.
“The Vertis production facility represents the most technologically advanced high-performance indoor cannabis cultivation system I have seen anywhere in the world,” said Ian Davidson, Segra’s Chief Business Development Officer. “Their innovative thinking, exceptional management talent, and one of the largest production footprints in the state positions Vertis to be highly disruptive in the California high-end indoor flower market. We are proud to partner with the team at Vertis and for the opportunity to help bolster their long-term success.”
Frank Gallagher, a Vertis founder and Managing Member, commented: “We are thrilled to partner with Segra as they represent true visionary leadership in the cannabis agriculture technology space. With our shared values regarding the importance of product quality, consistency, and science-backed approaches to production, this project is a great fit for Vertis, and we look forward to our collaboration.”
About The Vertis Group:
Vertis is an indoor cannabis company that specializes in growing high-quality craft cannabis at scale. The company’s vertically integrated facility was designed to foster the growth of cannabis down to a perfected science in a highly controlled environment to ensure repeatability and consistency harvest after harvest. Key technologies deployed by Vertis include the use of high-tech innovative grow rooms capable of precision climate control, made possible by the co-generation power plant built on site. The Vertis team is comprised of hardworking, purpose-driven individuals who share a deep adoration and reverence for cannabis. The company’s vision is driven by a mission to further the research and development of cannabis in a highly automated and controlled facility without use of synthetic chemicals or pesticides.
About Segra International:
Segra is an agriculture technology company offering plant tissue culture, plant genomics, and pathogen detection services to accelerate the advancement of the cannabis industry. The company’s proprietary technologies empower its clients to drive financial performance and mitigate risk while exploring the next frontier of optimized cultivation practices for the rapidly evolving cannabis consumer. Segra has developed industrial-scale laboratories to produce Verified Segra Stock™, robust, and DNA-fingerprinted cannabis plantlets for licensed producers globally. Segra has assembled a world-class team of specialists in the fields of agronomy, molecular genetics, plant tissue culture, and regulatory compliance to support this vision. Learn more at segra-intl.com or view the 2021 Cultivar and Services Catalogue.
Contact For Further Information
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.